J&J inks clinical trial deal with Stand Up To Cancer, latest pharma to join cancer nonprofit study efforts
$5 million sponsorship agreement between Janssen and Stand Up To Cancer aims to boost diversity in early phase clinical trials, helping to fund four groups of researchers across the US working to remove barriers to enrolling more patients, especially in “medically underserved” communities.